Concepedia

Kimberly S. Fuson

KS

Statistics

Publications

14

Citations

1.8K

H-Index

12

Active since

1992

Affiliations

Eli Lilly (United States)(Current)

CNS Research (United States)

Kimberly S. Fuson is an author at Eli Lilly (United States) specializing in neuroscience, life sciences, and molecular neuroscience.

Publications per year

1992–2004

14

Publications

14

Functional gamma‐secretase inhibitors reduce beta‐amyloid peptide levels in brain

Harry F. Dovey, Varghese John, J. P. Anderson et al. · Journal of Neurochemistry · 2001 · 879 citations · Full text

, , +17

Secondary structure of amyloid beta peptide correlates with neurotoxic activity in vitro.

Linda K. Simmons, Patrick C. May, K J Tomaselli et al. · Molecular Pharmacology · 1994 · 371 citations

, , +17

Neurotoxicity of Human Amylin in Rat Primary Hippocampal Cultures: Similarity to Alzheimer's Disease Amyloid‐<i>β</i> Neurotoxicity

Patrick C. May, Leonard N. Boggs, Kimberly S. Fuson · Journal of Neurochemistry · 1993 · 124 citations

, , +16

Clusterin (Apo J) Protects Against In Vitro Amyloid‐β(1–40) Neurotoxicity

Leonard N. Boggs, Kimberly S. Fuson, Melvyn Baez et al. · Journal of Neurochemistry · 1996 · 108 citations

, , +16

Amyloid β‐Mediated Oxidative and Metabolic Stress in Rat Cortical Neurons: No Direct Evidence for a Role for H<sub>2</sub>O<sub>2</sub> Generation

Zhiyuan Zhang, Russell E. Rydel, Gary J. Drzewiecki et al. · Journal of Neurochemistry · 1996 · 66 citations

, , +16

1–5 of 14